{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T23:55:33Z","timestamp":1785023733902,"version":"3.55.0"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Prostaglandins &amp; Other Lipid Mediators"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1016\/j.prostaglandins.2015.07.001","type":"journal-article","created":{"date-parts":[[2015,7,21]],"date-time":"2015-07-21T20:19:13Z","timestamp":1437509953000},"page":"163-169","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"PB","title":["Aspirin provocation increases 8-iso-PGE2 in exhaled breath condensate of aspirin-hypersensitive asthmatics"],"prefix":"10.1016","volume":"121","author":[{"given":"Lucyna","family":"Mastalerz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafa\u0142","family":"Januszek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marek","family":"Kaszuba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krzysztof","family":"W\u00f3jcik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Celejewska-W\u00f3jcik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Gielicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanna","family":"Plutecka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krzysztof","family":"Ole\u015b","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pawe\u0142","family":"Str\u0119k","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marek","family":"Sanak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.prostaglandins.2015.07.001_bib0005","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1016\/j.jchromb.2010.05.012","article-title":"Targeted eicosanoids lipidomics of exhaled breath condensate in healthy subjects","volume":"878","author":"Sanak","year":"2010","journal-title":"J. Chromatogr. B"},{"issue":"24","key":"10.1016\/j.prostaglandins.2015.07.001_bib0010","first-page":"441","article-title":"Isoprostanes: formation, analysis and use as indices of lipid peroxidation in vivo","volume":"274","author":"Lawson","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.prostaglandins.2015.07.001_bib0015","doi-asserted-by":"crossref","first-page":"895","DOI":"10.2174\/138161206776055985","article-title":"The isoprostanes-unique products of arachidonate peroxidation: their role as mediators of oxidant stress","volume":"12","author":"Morrow","year":"2006","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.prostaglandins.2015.07.001_bib0020","doi-asserted-by":"crossref","first-page":"4161","DOI":"10.1016\/S0021-9258(18)53593-6","article-title":"Identification of non-cyclooxygenase-derived prostanoid (F2-isoprostane) metabolites in human urine and plasma","volume":"268","author":"Awad","year":"1993","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.prostaglandins.2015.07.001_bib0025","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1016\/S0022-2275(20)32187-8","article-title":"Evidence that the E2-isoprostane, 15-E2t-isoprostane (8-iso-prostaglandin E2) is formed in vivo","volume":"39","author":"Morrow","year":"1998","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.prostaglandins.2015.07.001_bib0030","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/S0022-3565(24)38932-3","article-title":"Excitatory and inhibitory actions of isoprostanes in human and canine airway smooth muscle","volume":"295","author":"Janssen","year":"2000","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.prostaglandins.2015.07.001_bib0035","doi-asserted-by":"crossref","first-page":"183","DOI":"10.4168\/aair.2010.2.3.183","article-title":"The role of oxidative stress in the pathogenesis of asthma","volume":"2","author":"Cho","year":"2010","journal-title":"Allergy Asthma Immunol. Res."},{"key":"10.1016\/j.prostaglandins.2015.07.001_bib0040","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/j.bbagen.2011.04.016","article-title":"Isoprostanes and asthma","volume":"1810","author":"Voynow","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.prostaglandins.2015.07.001_bib0045","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/S1081-1206(10)62084-4","article-title":"The natural history and clinical characteristics of aspirin-exacerbated respiratory disease","volume":"89","author":"Berges-Gimeno","year":"2002","journal-title":"Ann. Alergy Asthma Immunol."},{"key":"10.1016\/j.prostaglandins.2015.07.001_bib0050","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1067\/mai.2003.1487","article-title":"Aspirin-induced asthma: advances in pathogenesis, diagnosis, and management","volume":"111","author":"Szczeklik","year":"2003","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.prostaglandins.2015.07.001_bib0055","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.ejphar.2005.12.053","article-title":"The broken balance in aspirin hypersensitivity","volume":"533","author":"Szczeklik","year":"2006","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.prostaglandins.2015.07.001_bib0060","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/S0140-6736(95)90799-8","article-title":"Prostaglandin E2 and aspirin-induced asthma","volume":"345","author":"Szczeklik","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.prostaglandins.2015.07.001_bib0065","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1136\/thx.2007.080903","article-title":"Prostaglandin E2 systemic production in patients with asthma with and without aspirin hypersensitivity","volume":"63","author":"Mastalerz","year":"2008","journal-title":"Thorax"},{"key":"10.1016\/j.prostaglandins.2015.07.001_bib0070","doi-asserted-by":"crossref","unstructured":"Expert Panel Report 3 (EPR-3): Guidelines for the Diagnosis and Management of Asthma-Summary Report 2007, J. Allergy Clin. Immunol. 120 (2007) S94\u2013138. 10.1016\/j.jaci.2007.09.043","DOI":"10.1016\/j.jaci.2007.09.043"},{"key":"10.1016\/j.prostaglandins.2015.07.001_bib0075","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jaci.2003.09.008","article-title":"Development of the asthma control test: a survey for assessing asthma control","volume":"113","author":"Nathan","year":"2004","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.prostaglandins.2015.07.001_bib0080","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1111\/j.1398-9995.2007.01409.x","article-title":"EAACI\/GA2LEN guideline: aspirin provocation tests for diagnosis of aspirin hypersensitivity","volume":"62","author":"Ni\u017cankowska-Mogilnicka","year":"2007","journal-title":"Allergy"},{"key":"10.1016\/j.prostaglandins.2015.07.001_bib0085","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1183\/09031936.05.00029705","article-title":"Exhaled breath condensate: methodological recommendations and unresolved questions","volume":"26","author":"Horv\u00e1th","year":"2005","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.prostaglandins.2015.07.001_bib0090","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/j.1365-2222.1995.tb01079.x","article-title":"Validation and application of a new simple strategy for measurements of urinary leukotriene E4 in humans","volume":"25","author":"Kumlin","year":"1995","journal-title":"Clin. Exp. Allergy"},{"key":"10.1016\/j.prostaglandins.2015.07.001_bib0095","doi-asserted-by":"crossref","first-page":"627","DOI":"10.2174\/092986732205150112104411","article-title":"Oxidative stress in COPD: molecular background and clinical monitoring","volume":"22","author":"Antus","year":"2015","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.prostaglandins.2015.07.001_bib0100","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1164\/rccm.2101021","article-title":"Increased exhaled cysteinyl-leukotrienes and 8-isoprostane in aspirin-induced asthma","volume":"166","author":"Antczak","year":"2002","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.prostaglandins.2015.07.001_bib0105","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1165\/rcmb.2006-0295OC","article-title":"8-iso-PGE2 stimulates anion efflux from airway epithelial cells via the EP4 prostanoid receptor","volume":"38","author":"Joy","year":"2008","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.prostaglandins.2015.07.001_bib0110","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/sj.bjp.0703784","article-title":"Vasoconstrictor actions of isoprostanes via tyrosine kinase and Rho kinase in human and canine pulmonary vascular smooth muscles","volume":"132","author":"Janssen","year":"2001","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.prostaglandins.2015.07.001_bib0115","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.ejphar.2006.05.044","article-title":"Aspirin induces the production of the inflammatory mediator 8-epi-PGF in mast cells","volume":"543","author":"Mortaz","year":"2006","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.prostaglandins.2015.07.001_bib0120","doi-asserted-by":"crossref","first-page":"9800","DOI":"10.1074\/jbc.270.17.9800","article-title":"Cyclooxygenase-dependent formation of the isoprostane, 8-epi prostaglandin F2 alpha","volume":"270","author":"Pratico","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.prostaglandins.2015.07.001_bib0125","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1111\/j.1476-5381.1996.tb15535.x","article-title":"Induction of prostaglandin endoperoxide synthase-2 in human monocytes associated with cyclo-oxygenase-dependent F2-isoprostane formation","volume":"118","author":"Patrignani","year":"1996","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.prostaglandins.2015.07.001_bib0130","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/j.jaci.2010.12.1108","article-title":"Targeted eicosanoid lipidomics of exhaled breath condensate provide a distinct pattern in the aspirin-intolerant asthma phenotype","volume":"127","author":"Sanak","year":"2011","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.prostaglandins.2015.07.001_bib0135","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1164\/ajrccm.154.6.8970343","article-title":"Bronchial aspirin challenge causes specific eicosanoid response in aspirin-sensitive asthmatics","volume":"154","author":"Szczeklik","year":"1996","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.prostaglandins.2015.07.001_bib0140","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/j.jaci.2009.12.977","article-title":"Profile of eicosanoid generation in aspirin-intolerant asthma and anaphylaxis assessed by new biomarkers","volume":"125","author":"Higashi","year":"2010","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.prostaglandins.2015.07.001_bib0145","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1111\/all.12512","article-title":"Induced sputum eicosanoids during aspirin bronchial challenge of asthmatic patients with aspirin hypersensitivity","volume":"69","author":"Mastalerz","year":"2014","journal-title":"Allergy"},{"key":"10.1016\/j.prostaglandins.2015.07.001_bib0150","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1111\/j.1365-2222.2004.02123.x","article-title":"Exhaled eicosanoids following oral aspirin challenge in asthmatic patients","volume":"34","author":"Sanak","year":"2004","journal-title":"Clin. Exp. Allergy"},{"key":"10.1016\/j.prostaglandins.2015.07.001_bib0155","doi-asserted-by":"crossref","first-page":"423","DOI":"10.20452\/pamw.1841","article-title":"Altered metabolism of prostaglandin E2 in asthma patients with aspirin hypersensitivity","volume":"123","author":"Mastalerz","year":"2013","journal-title":"Pol. Arch. Med Wewn\u0119trznej."},{"key":"10.1016\/j.prostaglandins.2015.07.001_bib0160","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.iac.2007.09.001","article-title":"Exhaled breath condensate: an overview","volume":"27","author":"Hunt","year":"2007","journal-title":"Immunol. Allergy Clin. North Am."},{"key":"10.1016\/j.prostaglandins.2015.07.001_bib0165","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1111\/j.1398-9995.2009.02206.x","article-title":"Elevated urinary leukotriene E excretion in asthma: a comparison of HPLC-mass spectrometry and ELISA","volume":"65","author":"Sanak","year":"2010","journal-title":"Allergy"},{"key":"10.1016\/j.prostaglandins.2015.07.001_bib0170","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1183\/09031936.93.06030391","article-title":"Cysteinyl leukotrienes overproduction and mast cell activation in aspirin-provoked bronchospasm in asthma","volume":"6","author":"Sladek","year":"1993","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.prostaglandins.2015.07.001_bib0175","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S0091-6749(99)70324-6","article-title":"Association of urinary leukotriene E4 excretion during aspirin challenges with severity of respiratory responses","volume":"104","author":"Daffern","year":"1999","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.prostaglandins.2015.07.001_bib0180","doi-asserted-by":"crossref","first-page":"696792","DOI":"10.1155\/2012\/696792","article-title":"Exhaled eicosanoids following bronchial aspirin challenge in asthma patients with and without aspirin hypersensitivity: the pilot study","volume":"2012","author":"Mastalerz","year":"2012","journal-title":"J. Allergy"}],"container-title":["Prostaglandins &amp; Other Lipid Mediators"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098882315300022?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098882315300022?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T14:34:24Z","timestamp":1748529264000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1098882315300022"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":36,"alternative-id":["S1098882315300022"],"URL":"https:\/\/doi.org\/10.1016\/j.prostaglandins.2015.07.001","relation":{},"ISSN":["1098-8823"],"issn-type":[{"value":"1098-8823","type":"print"}],"subject":[],"published":{"date-parts":[[2015,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Aspirin provocation increases 8-iso-PGE2 in exhaled breath condensate of aspirin-hypersensitive asthmatics","name":"articletitle","label":"Article Title"},{"value":"Prostaglandins & Other Lipid Mediators","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prostaglandins.2015.07.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}